As of Feb 20, 2025, Fresenius Medical Care AG & Co. KGaA Intrinsic Value is $51.4. This suggests it may be undervalued by 123.9% compared to its current price of around $22.9.
As of Feb 20, 2025, Fresenius Medical Care AG & Co. KGaA's Discounted Cash Flow (DCF) valuation estimates its share price at $65.7. This suggests it may be overvalued by 186.3% to its current price of around $22.9, using a discount rate of 4.8% and terminal growth rate of 3.0%.
Fresenius Medical Care AG & Co. KGaA is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $51.4, compared to a market price of around $22.9. This suggests a potential undervaluation of 123.9%.